Current progress in non-invasive imaging of beta cell mass of the endocrine pancreas.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Current Medicinal Chemistry

• Publication date

  2006-09-30

• Fields of study

  Medicine

• Identifiers
  DOI 10.2174/092986706778521940PMID 17073627
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Localization of vesicular monoamine transporter isoforms (VMAT1 and VMAT2) to endocrine cells and neurons in rat

  2007cited by this paper
• Biochemical consequences of alginate encapsulation: a NMR study of insulin-secreting cells.

  2006cited by this paper
• Longitudinal noninvasive PET-based beta cell mass estimates in a spontaneous diabetes rat model.

  2006cited by this paper
• In vivo imaging of islet transplantation

  2006cited by this paper
• Noninvasive diagnosis of focal hyperinsulinism of infancy with [18F]-DOPA positron emission tomography.

  2006cited by this paper
• Diabetes and obesity: the twin epidemics

  2006cited by this paper
• The unique cytoarchitecture of human pancreatic islets has implications for islet cell function

  2006cited by this paper
• Peptide-mediated targeting of the islets of Langerhans.

  2005cited by this paper
• Specific dynamic and noninvasive labeling of pancreatic beta cells in reporter mice.

  2005cited by this paper
• Immunogenetics of Type 1 Diabetes

  2005cited by this paper
• Magnetic Resonance Imaging of Pancreatic Islets in Tolerance and Rejection

  2005cited by this paper
• Quantitative evaluation of a monoclonal antibody and its fragment as potential markers for pancreatic beta cell mass.

  2005cited by this paper
• Autoantibodies in diabetes.

  2005cited by this paper
• Assessment of Human Pancreatic Islet Architecture and Composition by Laser Scanning Confocal Microscopy

  2005cited by this paper
• Imaging beta-cell death with a near-infrared probe.

  2005cited by this paper
• Innovative Immune-Based Therapeutic Approaches for the Treatment of Type 1 Diabetes Mellitus

  2005cited by this paper
• Five-year follow-up after clinical islet transplantation.

  2005cited by this paper
• Characterization of hyperinsulinism in infancy assessed with PET and 18F-fluoro-L-DOPA.

  2005cited by this paper
• Optical imaging of pancreatic beta cells in living mice expressing a mouse insulin I promoter‐firefly luciferase transgene

  2005cited by this paper
• Magnetic resonance imaging of intrahepatically transplanted islets using paramagnetic beads.

  2005cited by this paper
• Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.

  2005cited by this paper
• Noninvasive imaging of pancreatic inflammation and its reversal in type 1 diabetes.

  2005cited by this paper
• In vitro and in vivo evaluation of novel glibenclamide derivatives as imaging agents for the non-invasive assessment of the pancreatic islet cell mass in animals and humans.

  2005cited by this paper
• When Two Is Better Than One: Elements of Intravital Microscopy

  2005cited by this paper
• Assessment of Pancreatic Islet Mass after Islet Transplantation Using In Vivo Bioluminescence Imaging

  2005cited by this paper
• Insulin secretion in type 1 diabetes.

  2004cited by this paper
• Radiation dose estimates in humans for (11)C-acetate whole-body PET.

  2004cited by this paper
• Lilly lecture 2003: the struggle for mastery in insulin action: from triumvirate to republic.

  2004cited by this paper
• Identification of tissue-restricted transcripts in human islets.

  2004cited by this paper
• Tracking the recruitment of diabetogenic CD8+ T-cells to the pancreas in real time.

  2004cited by this paper
• Challenges facing islet transplantation for the treatment of type 1 diabetes mellitus.

  2004cited by this paper
• MRI of transplanted pancreatic islets

  2004cited by this paper
• Prevalence of hepatic steatosis after islet transplantation and its relation to graft function.

  2004cited by this paper
• Neuronal traits are required for glucose‐induced insulin secretion

  2004cited by this paper
• Systematic screening of potential beta-cell imaging agents.

  2004cited by this paper
• Synthesis and in vitro evaluation of (S)-2-([11C]methoxy)-4-[3-methyl-1-(2-piperidine-1-yl-phenyl)-butyl-carbamoyl]-benzoic acid ([11C]methoxy-repaglinide): a potential beta-cell imaging agent.

  2004cited by this paper
• Autoreactive T cells in human type 1 diabetes.

  2004cited by this paper
• TOWARD DEVELOPMENT OF IMAGING MODALITIES FOR ISLETS AFTER TRANSPLANTATION: INSIGHTS FROM THE NATIONAL INSTITUTES OF HEALTH WORKSHOP ON BETA CELL IMAGING

  2004cited by this paper
• Magnetic resonance-defined periportal steatosis following intraportal islet transplantation: a functional footprint of islet graft survival?

  2003cited by this paper
• A new look at viruses in type 1 diabetes.

  2003cited by this paper
• Gene expression profiling in islet biology and diabetes research

  2003cited by this paper
• Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes.

  2003cited by this paper
• A comprehensive guide to antibody and T-cell responses in type 1 diabetes.

  2003cited by this paper
• Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study.

  2003cited by this paper
• Loss of beta-cell mass leads to a reduction of pulse mass with normal periodicity, regularity and entrainment of pulsatile insulin secretion in Göttingen minipigs

  2003cited by this paper
• Expression of the Two Isoforms of the Vesicular Monoamine Transporter (VMAT1 and VMAT2) in the Endocrine Pancreas and Pancreatic Endocrine Tumors

  2003cited by this paper
• Measurements of insulin secretory capacity and glucose tolerance to predict pancreatic beta-cell mass in vivo in the nicotinamide/streptozotocin Göttingen minipig, a model of moderate insulin deficiency and diabetes.

  2003cited by this paper
• Early, selective, and marked loss of sympathetic nerves from the islets of BioBreeder diabetic rats.

  2002cited by this paper
• MRI of insulitis in autoimmune diabetes

  2002cited by this paper
• Importance of the GLUT2 glucose transporter for pancreatic beta cell toxicity of alloxan

  2002cited by this paper
• Pancreatic uptake of [2-(14)C]alloxan.

  2001cited by this paper
• Noninvasive in vivo measurement of beta-cell mass in mouse model of diabetes.

  2001cited by this paper
• Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.

  2001cited by this paper
• The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas.

  2001cited by this paper
• Pancreatic fate of a 125I‐labelled mouse monoclonal antibody directed against pancreatic B‐cell surface ganglioside(s) in control and diabetic rats

  2001cited by this paper
• Role of pancreatic beta-cells in the process of beta-cell death.

  2001cited by this paper
• Decrease in beta-cell mass leads to impaired pulsatile insulin secretion, reduced postprandial hepatic insulin clearance, and relative hyperglucagonemia in the minipig.

  2001cited by this paper
• Pancreatic fate of D‐[3H] mannoheptulose

  2001cited by this paper
• Chemical neuroanatomy of the vesicular amine transporters

  2000cited by this paper
• The Rising Incidence of Childhood Type 1 Diabetes in New South Wales, Australia

  2000cited by this paper
• Pancreatic fate of 6-deoxy-6-[125I]iodo-D-glucose: in vitro experiments.

  2000cited by this paper
• Insulitis in an autoimmune-mediated patient originally classified as having type 2 diabetes.

  1999cited by this paper
• Detection of single mammalian cells by high-resolution magnetic resonance imaging.

  1999cited by this paper
• Increased beta-cell proliferation and reduced mass before diabetes onset in the nonobese diabetic mouse.

  1999cited by this paper
• Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial. The Diabetes Control and Complications Trial Research Group.

  1998cited by this paper
• PET instrumentation: what are the limits?

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• Imaging of the pancreas and related diseases with PET carbon-11-acetate.

  1997cited by this paper
• Expression of Neuronal Traits in Pancreatic Beta Cells

  1997cited by this paper
• Seminars in Medicine of the Beth Israel Hospital, Boston. Non-insulin-dependent diabetes mellitus - a genetically programmed failure of the beta cell to compensate for insulin resistance.

  1996cited by this paper
• Differentiation and growth of pancreatic beta cells.

  1996cited by this paper
• Medical Care for Patients with Diabetes: Epidemiologic Aspects

  1996cited by this paper
• Prediction of Type I Diabetes in First-Degree Relatives Using a Combination of Insulin, GAD, and ICA512bdc/IA-2 Autoantibodies

  1996cited by this paper
• In vivo imaging of the brain vesicular monoamine transporter.

  1995cited by this paper
• Clinical perspectives on type 2 diabetes in North America.

  1995cited by this paper
• Insulin Action, Diabetogenes, and the Cause of Type II Diabetes

  1994cited by this paper
• Correlations of in vivo beta-cell function tests with beta-cell mass and pancreatic insulin content in streptozocin-administered baboons.

  1991cited by this paper
• Incidence of Type II Diabetes in Mexican Americans Predicted by Fasting Insulin and Glucose Levels, Obesity, and Body-Fat Distribution

  1990cited by this paper
• Mapping Genes in Diabetes: Genetic Epidemiological Perspective

  1990cited by this paper
• A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes.

  1990cited by this paper
• Prevalence of Complications Among Second-Generation Japanese-American Men With Diabetes, Impaired Glucose Tolerance, or Normal Glucose Tolerance

  1987cited by this paper
• Simulation of the normal glucopenia-induced decline in insulin partially restores the glucagon response to glucopenia in isolated perfused pancreata of streptozotocin-diabetic rats.

  1986cited by this paper
• The Influence of Body Fat Distribution on the Incidence of Diabetes Mellitus: 13.5 Years of Follow-up of the Participants in the Study of Men Born in 1913

  1985cited by this paper
• Congenital rubella syndrome as a model for Type 1 (insulin-dependent) diabetes mellitus: increased prevalence of islet cell surface antibodies

  1984cited by this paper
• The catecholamine carrier of bovine chromaffin granules. Form of the bound amine.

  1983cited by this paper
• Partial pancreatectomy in the rat and subsequent defect in glucose-induced insulin release.

  1983cited by this paper
• Characterization of the monoamine carrier of chromaffin granule membrane by binding of [2-3H]dihydrotetrabenazine.

  1983cited by this paper
• Diabetes incidence in Pima indians: contributions of obesity and parental diabetes.

  1981cited by this paper
• Diabetes in identical twins

  1981cited by this paper
• The Effect of Insulin on the Disposal of Intravenous Glucose: Results from Indirect Calorimetry and Hepatic and Femoral Venous Catheterization

  1981cited by this paper
• The pancreatic islets in diabetes.

  1981cited by this paper
• Effect of drugs on the ATP-induced and pH-gradient-driven monoamine transport by bovine chromaffin granules.

  1980cited by this paper
• Differential volumetry of A, B and D cells in the pancreatic islets of diabetic and nondiabetic subjects.

  1979cited by this paper
• Isolation of a virus from the pancreas of a child with diabetic ketoacidosis.

  1979cited by this paper
• Kinetics of human connecting peptide in normal and diabetic subjects.

  1978cited by this paper
• Pathologic Anatomy of the Pancreas in Juvenile Diabetes Mellitus

  1965cited by this paper

• Serotonin transporter imaging agent as a probe for β-cells of pancreas.

  2024cites this paper
• Polymer-Based Nanostructures for Pancreatic Beta-Cell Imaging and Non-Invasive Treatment of Diabetes

  2023cites this paper
• CHARACTERIZING NOVEL GLUCAGON-LIKE PEPTIDE-1 DERIVATIVES FOR NUCLEAR IMAGING OF THE PANCREATIC BETA CELLS

  2021influential citation
• Glucagon‐Like Peptide‐1 Receptor Activators

  2021cites this paper
• Visual interpretation, not SUV ratios, is the ideal method to interpret 18F-DOPA PET scans to aid in the cure of patients with focal congenital hyperinsulinism

  2020cites this paper
• Imaging endocrinology in animal models of endocrine disease.

  2018cites this paper
• Pancreatic imaging: Current status of clinical practices and small animal studies

  2017cites this paper
• The impact of IUGR on pancreatic islet development and β-cell function.

  2017cites this paper
• Beta Cell Imaging as Part of “Imaging on Metabolic Diseases”

  2017cites this paper
• PET probes for imaging pancreatic islet cells

  2017cites this paper
• A Novel Potential Positron Emission Tomography Imaging Agent for Vesicular Monoamine Transporter Type 2

  2016cites this paper
• Glucagon-Like Peptide-1 and Its Class B G Protein–Coupled Receptors: A Long March to Therapeutic Successes

  2016influential citation
• Imaging pancreatic islet cells by positron emission tomography

  2016cites this paper
• Multivalent glibenclamide to generate islet specific imaging probes.

  2016cites this paper
• Development of a peptide-functionalized imaging nanoprobe for the targeting of (FXYD2)γa as a highly specific biomarker of pancreatic beta cells.

  2015cites this paper
• A Synthetic Heterobivalent Ligand Composed of Glucagon-Like Peptide 1 and Yohimbine Specifically Targets β Cells Within the Pancreas

  2015cites this paper
• A porcine type 1 Diabetes Mellitus model, for non-invasive in vivo imaging of the glucagon-like peptide-1 receptor in the pancreas, using [68Ga]Ga-DO3A-VS-Cys40-conjugated synthetic exendin-4 in PET-CT

  2015cites this paper
• Derivatization of (±) dihydrotetrabenazine for copper-64 labeling towards long-lived radiotracers for PET imaging of the vesicular monoamine transporter 2.

  2014cites this paper
• Glucagon-like Peptide-1 (GLP-1) Analogs: Recent Advances, New Possibilities, and Therapeutic Implications

  2014cites this paper
• Hetero‐bivalent GLP‐1/Glibenclamide for Targeting Pancreatic β‐Cells

  2014cites this paper
• Positron emission tomography imaging of the glucagon-like peptide-1 receptor in healthy and streptozotocin-induced diabetic pigs

  2014influential citation
• Positron emission tomography study on pancreatic somatostatin receptors in normal and diabetic rats with 68Ga-DOTA-octreotide: a potential PET tracer for beta cell mass measurement.

  2013cites this paper
• Species-specific vesicular monoamine transporter 2 (VMAT2) expression in mammalian pancreatic beta cells: implications for optimising radioligand-based human beta cell mass (BCM) imaging in animal models

  2013cites this paper
• Molecular Imaging Methods in Diabetes-Related Studies

  2013cites this paper
• Combinatorial Targeting of the Glucagon-Like Peptide-1 And Sulfonylurea-1 Receptors Using a Complimentary Multivalent Glucagon-Like Peptide-1/Glibenclamide Ligand for the Improvement of β-Cell Targeting Agents and Diabetic Treatment

  2013cites this paper
• Studies on the possible mechanisms behind the anti-diabetic effects of Xylitol.

  2013cites this paper
• Imaging of the β-cells of the islets of Langerhans.

  2012cites this paper
• Multimodal imaging of pancreatic beta cells in vivo by targeting transmembrane protein 27 (TMEM27)

  2012cites this paper
• Non‐invasive in vivo imaging of pancreatic β‐cell function and survival – a perspective

  2012cites this paper
• Quantitative pancreatic β cell MRI using manganese‐enhanced Look‐Locker imaging and two‐site water exchange analysis

  2012cites this paper
• Pretargeting vs. direct targeting of human betalox5 islet cells subcutaneously implanted in mice using an anti-human islet cell antibody.

  2012cites this paper
• Neurofunctional imaging of β‐cell dynamics

  2012cites this paper
• Molecular imaging for diagnosis and management of diabetes - a review

  2012cites this paper
• Quantitative Determination of Apoptosis of Pancreatic β-Cells in a Murine Model of Type 1 Diabetes Mellitus

  2012cites this paper
• Imaging of β-cell mass and insulitis in insulin-dependent (Type 1) diabetes mellitus.

  2012cites this paper
• Radioisotopes in Drug Research and Development: Focus on Positron Emission Tomography

  2011cites this paper
• Accurate measurement of pancreatic islet β-cell mass using a second-generation fluorescent exendin-4 analog

  2011cites this paper
• DB110726 2853..2860

  2011cites this paper
• Sigma receptor binding of tetrabenazine series tracers targeting VMAT2 in rat pancreas.

  2011cites this paper
• High-Resolution Magnetic Resonance Imaging Quantitatively Detects Individual Pancreatic Islets

  2011cites this paper
• Human islet cell MORF/cMORF pretargeting in a xenogeneic murine transplant model.

  2011cites this paper
• Potential of nucleofected human MSCs for insulin secretion

  2011cites this paper
• Experimental Approaches for High-Resolution In Vivo Imaging of Islet of Langerhans Biology

  2011cites this paper
• Preparation of (111)In-DTPA morpholino oligomer for low abdominal accumulation.

  2010cites this paper
• Near-infrared fluorescent probe for imaging of pancreatic beta cells.

  2010cites this paper
• A Model for Glucose, Insulin, and Beta‐Cell Dynamics in Subjects With Insulin Resistance and Patients With Type 2 Diabetes

  2010cites this paper
• Consequences of a compromised intrauterine environment on islet function.

  2010cites this paper
• Radionuclide probes for molecular imaging of pancreatic beta-cells.

  2010cites this paper
• Towards high resolution optical imaging of beta cells in vivo.

  2010cites this paper
• Approaches for imaging islets: recent advances and future prospects.

  2010cites this paper
• In vitro phage display in a rat beta cell line: a simple approach for the generation of a single-chain antibody targeting a novel beta cell-specific epitope

  2010cites this paper
• Three-dimensional optical method for integrated visualization of mouse islet microstructure and vascular network with subcellular-level resolution.

  2010cites this paper
• MR imaging of pancreatic islets: tracking isolation, transplantation and function.

  2010cites this paper
• Binding characteristics of 9-fluoropropyl-(+)-dihydrotetrabenzazine (AV-133) to the vesicular monoamine transporter type 2 in rats.

  2010cites this paper
• In vivo imaging of pancreatic endocrine islets

  2009influential citation
• In vivo imaging of endocrine islets of Langerhans in mice with extended focus Optical Coherence Microscopy Author list:

  2009influential citation
• In vivo imaging of murine endocrine islets of Langerhans with extended-focus optical coherence microscopy

  2009cites this paper
• In vivo imaging of VMAT2 in pancreas using a 18 F epoxide derivative of tetrabenazine

  2009cites this paper
• Beta-cell function and mass in type 2 diabetes.

  2009cites this paper
• Noninvasive imaging of pancreatic β cells

  2009cites this paper
• β-Cell Protection and Therapy for Latent Autoimmune Diabetes in Adults

  2009cites this paper
• Noninvasive monitoring of changes in pancreatic beta-cell mass by bioluminescent imaging in MIP-luc transgenic mice.

  2009cites this paper
• Evaluating Protocols for Embryonic Stem Cell Differentiation into Insulin-Secreting β-Cells Using Insulin II-GFP as a Specific and Noninvasive Reporter

  2009cites this paper
• Pancreatic Imaging with 11C-Dihydrotetrabenazine PET: A Perspective

  2009cites this paper
• CHARACTERISTICS OF THE MODEL OF MILD DIABETES IN GÖTTINGEN MINIPIGS Diabetes

  2009cites this paper
• Portal Vein Embolization with Radiolabeled Polyvinyl Alcohol Particles in a Swine Model: Hepatic Distribution and Implications for Pancreatic Islet Cell Transplantation

  2009cites this paper
• Enhanced Cholinergic Response in Pancreata of Nonhuman Primates with Impaired Glucose Tolerance Shown on [18F]Fluorobenzyltrozamicol Positron Emission Tomography

  2009cites this paper
• Imaging the pancreas: from ex vivo to non-invasive technology

  2008cites this paper
• In Vivo Imaging of β-Cell Mass in Rats Using 18F-FP-(+)-DTBZ: A Potential PET Ligand for Studying Diabetes Mellitus

  2008influential citation
• VMAT2 gene expression and function as it applies to imaging beta-cell mass.

  2008cites this paper
• Noninvasive Monitoring of Changes in Pancreatic Beta-cell Mass by Bioluminescent Imaging in MIP-luc Transgenic Mice

  2008cites this paper
• Labeling of pancreatic islets with iron oxide nanoparticles for in vivo detection with magnetic resonance.

  2008cites this paper
• Advances in molecular imaging of pancreatic beta cells.

  2008cites this paper
• In vivo imaging of vesicular monoamine transporter 2 in pancreas using an (18)F epoxide derivative of tetrabenazine.

  2008cites this paper
• Role of vesicular monoamine transporter type 2 in rodent insulin secretion and glucose metabolism revealed by its specific antagonist tetrabenazine.

  2008cites this paper
• Covariate Model Building in Nonlinear Mixed Effects Models

  2007cites this paper
• VMAT2 gene expression and function as it applies to imaging β-cell mass

  2007cites this paper
• Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Pharmacy 59 Covariate Model Building in Nonlinear Mixed Effects Models

  2007cites this paper
• Models for pharmacological activation of beta-cell regeneration in diabetes

  2007cites this paper